Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Current Leases (2021 - 2025)

Roivant Sciences' Current Leases history spans 5 years, with the latest figure at $10.4 million for Q4 2025.

  • For Q4 2025, Current Leases rose 6.11% year-over-year to $10.4 million; the TTM value through Dec 2025 reached $10.4 million, up 6.11%, while the annual FY2025 figure was $9.8 million, 9.77% up from the prior year.
  • Current Leases reached $10.4 million in Q4 2025 per ROIV's latest filing, up from $9.0 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $12.3 million in Q1 2021 to a low of $9.0 million in Q1 2024.
  • Average Current Leases over 5 years is $10.7 million, with a median of $11.1 million recorded in 2021.
  • Peak YoY movement for Current Leases: fell 23.32% in 2024, then grew 9.77% in 2025.
  • A 5-year view of Current Leases shows it stood at $11.2 million in 2021, then rose by 5.53% to $11.9 million in 2022, then fell by 11.68% to $10.5 million in 2023, then dropped by 6.13% to $9.8 million in 2024, then increased by 6.11% to $10.4 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Current Leases are $10.4 million (Q4 2025), $9.0 million (Q3 2025), and $9.4 million (Q2 2025).